baber/WOPTO huggingface dataset:
Patent EP-0519782-A1 (EP)
Inventor: BELOT GERARD
IPC: B65D5/44
Filed: 1992-06-05
Abstract: The subject of the present invention is a container (1) for transporting and displaying products, in particular bags of crisps, comprising a bottom (1a), vertical walls (2, 3, 4, 5), a lid (6) intended to be placed on the upper part of the said walls and at least one inset plate (7) forming a shelf. The container comprises means (10) for supporting the inset plate (7) and for stiffening at least two opposite vertical walls (3, 5). <IMAGE>
Patent EP-0528703-A1 (EP)
Inventor: MARTIN JEAN MAX
IPC: G06F13/38
Filed: 1992-07-10
Abstract: The programmable logic controllers (A1,...,A4) of this set (E) communicate with each other and with the environment external to the set according to an asynchronous communication mode only (2%). Each programmable logic controller (A1,...,A4) is a combination of programmable logic sub-controllers (S1,...,S16) each programmable logic sub-controller including at least one interface (I1,...,I7) external to a programmable logic controller. All the programmable logic controllers of a single programmable logic controller communicate with each other by a single communications mode called pseudo-synchronous mode (3%) according to which the events constituting a communication are synchronous with respect to the environment external to the programmable logic sub-controllers in communication, and are asynchronous with respect to the environment internal to these programmable logic sub-controllers. Each programmable logic sub-controller (S1,...,S16) is a combination of basic programmable logic controllers (B1,...,B41) called bricks, all the bricks of a single progammable logic sub-controller communicating with each other by the synchronous communications mode only (1%). Application to software for telephone exchanges. <IMAGE>
Patent EP-0541418-A1 (EP)
Inventor: BRUN ANDRE
IPC: C12N7/00
Filed: 1992-10-22
Abstract: The method for isolation of the mystery disease virus entails removal of organs of sick or infected pigs, grinding of the removed material and passaging of the supernatant from grinding through sensitive heterologous or homologous cells, followed by harvesting of the supernatant. For the industrial production of mystery disease virus, the virus is cultured on sensitive heterologous or homologous cells. The preparations of purified mystery disease viral antigen comprise attenuated or unattenuated live viral particles or inactivated particles or antigens of subunits or antigens expressed by genetic recombination from genes of the isolated virus. Vaccines containing a vaccinating amount of such an antigen.
Patent EP-0584423-A1 (EP)
Inventor: BOUCKNOOGHE XAVIER
IPC: B65H75/28
Filed: 1992-11-03
Abstract: The present invention relates to an unrolling method for a flexible plant support, or string (2), for cultivating climbing plants, this string (2) being rolled up at least partially on a first part (3) of a unwinder (1) which is normally formed by a metal wire bent flat, said method being characterised in that it consists in pulling off, without unrolling turn by turn, a skein (10) of a string rolled up to this end on a second part (8) of said unwinder (1). <IMAGE>
Patent EP-0550344-A1 (EP)
Inventor: NITZSCHE REMI
IPC: A61N1/39
Filed: 1992-12-30
Abstract: Comparison of the auricular and ventricular rates, and examination of the criteria of stability of the PR intervals, of stability of the RR intervals, and of the acceleration of the ventricular rate after auriculoventricular desynchronisation, ensures control of the defibrillator only in the events of ventricular tachycardia. <IMAGE>
Patent EP-0514302-A1 (EP)
Inventor: GANTZER CHRISTIAN
IPC: A01D78/10
Filed: 1992-05-07
Abstract: The present invention relates to an agricultural machine, especially a crop windrower possessing a load-bearing structure consisting of at least one beam, which load-bearing structure possesses two arms each carrying a raking wheel. According to the invention, the two arms (8 and 9) which carry the raking wheels (10, 11) are offset with respect to one another, considered in the direction of forward travel (D) of the machine, in the working position, the two raking wheels (10, 11) are situated partially under the beam (2) of the load-bearing structure, so that the trajectories of their respective forks (24) partially overlap and, they rotate in the same rotational direction (F). <IMAGE>
Patent EP-0527101-A1 (EP)
Inventor: SALINERO RODERO MIGUEL ANGEL
IPC: A61K36/00
Filed: 1992-07-09
Abstract: The new compositions of the invention are formed by the total acid fraction obtained by alkali hydrolysis of the lipid extracts of the fruit of Sabal serrulata. Said compositions have an effective adrenergic antagonist action and a complementary antiinflammatory action, together with a high degree of innocuity and slight side effects, making its use highly effective for combatting prostate affections and, more particularly, benign hypertrophy of the prostate.
Patent EP-0520947-A1 (EP)
Title: Method and device to maintain groups of warp yarns separate while passing through a dyeing apparatus.
Inventor: BENZ GOTTLIEB
IPC: D03J1/18
Filed: 1992-06-22
Abstract: In a yarn-dyeing apparatus, a sewing station (20) is inserted after the warp-beam frame (1) at the start of the production line. The sewing station consists of two independent and displaceable sewing units (20', 20"). These connect the starting and end regions of the upper web (11) and of the lower web (12) to one another, in that, without the production speed or the yarn tension being influenced, a lower and an upper textile or plastic-coated webbing (31, 32) is respectively sewn on. Starting and end regions of the upper and lower webs (11, 12) can thus pass through the dyeing apparatus, without the nip roller being opened. The yarns are dyed uniformly and a soiling of the rollers located after the nip rollers by excess pretreatment agents is prevented. The webbing can easily be removed again at the end of the production line, before the yarn is wound. <IMAGE>
Patent EP-0593839-A1 (EP)
Inventor: WIKLUND HENRY WILHELM
IPC: F16N29/04
Filed: 1992-09-21
Abstract: A pressure fluid actuated lubricator having a housing (46), a pressure fluid channel (43, 42, 21) leading from an inlet opening (2) to an outlet opening (7), a reservoir (44) for a lubricant and a discharge device (19) for the lubricant. The reservoir (44) is arranged to be movable by being acted on by the pressure fluid and transfers the pressure force to the lubricant and the discharge device (19). The reservoir is sealed against the penetration of pressure fluid and decreases in effective volume in proportion to the discharged amount of lubricant.
Patent EP-0580581-A1 (EP)
Inventor: MELLORS ALAN
IPC: A61K35/28
Filed: 1992-11-06
Abstract: On décrit une méthode de récupération de cellules viables dont les déterminants des protéines superficielles présentent des zones riches en hydrates de carbone à glycosylation O. Les protéines sont caractérisées par des déterminants qui sont sensibles au niveau du substrat à une neutralmétallo-glycoprotéase dérivée de P. haemolytica. La glycoprotéase présente une spécificité très restreinte lui permettant d'effectuer le clivage, sur les surfaces des cellules, uniquement des parties à protéine à glycosylation O contenant les déterminants, tout en préservant la viabilité des cellules. Ladite méthode comprend: i) la mise en contact des cellules en solution avec des matrices d'affinité qui se lient spécifiquement à un ou à plusieurs déterminants faisant partie des substrats sensibles à la glycoprotéase, les matrices ayant la possiblité de se lier aux déterminants sur les cellules; ii) la séparation des cellules auxquelles sont liées les matrices d'affinité de toute matière restant en solution, les matrices d'affinité ayant une affinité de liaison pour les déterminants telle qu'elles restent liées aux déterminants pendant la séparation; iii) la mise en contact de la glycoprotéase avec les cellules séparées dans une concentration et pendant une durée suffisantes pour effectuer le clivage uniquement des parties du substrat des protéines présentant les déterminants et liées par les matrices d'affinité, de manière à libérer ainsi les cellules des matrices d'affinité. Les cellules libérées conservent leur viabilité en raison de la spécificité restreinte de la glycoprotéase qui effectue le clivage uniquement des parties des protéines à glycosylation O présentant les déterminants, et iv) la récupération des cellules ainsi libérées.
Patent EP-0522169-A1 (EP)
Inventor: OKADA YASUNORI
IPC: C07K16/00
Filed: 1992-01-21
Abstract: The invention provides as an antibody against human stromelysin a monoclonal antibody which has an immunoreactivity with only one of the antigenic determinants present in human stromelysin and reacts with either of cryptic and active stromelysins indiscriminatingly. The concurrent use of two kinds of monoclonal antibodies, each of which specifically combines with one of the two different antigenic determinants of human stromelysin, allows human stromelysin present in the bodily fluid to be accurately determined, thus enabling diagnosis of rheumatoid arthritis. The invention provides a method of enzyme immumoassay of human stromelysin present in the bodily fluid by the sandwich technique using the above monoclonal antibody itself and two kinds thereof, and a method of diagnosing rheumatoid arthritis thereby.
Patent EP-0527973-A1 (EP)
Inventor: DUFF DANIEL H
IPC: A61M1/34
Filed: 1991-12-06
Abstract: Un système de traitement (30) sépare une suspension (32) riche en matière cellulaire en un premier constituant cellulaire (36) et un second constituant (38) dépourvu de substance cellulaire. Le système (30) comprend une zone de séparation (40) qui reçoit la suspension (32) riche en matière cellulaire et d'où sont évacués les premier (36) et second (38) constituants. Le système (30) coordonne l'écoulement de la suspension (32) riche en matière cellulaire dans la zone de séparation (40) avec l'écoulement du second constituant (38) dépourvu de cette matière hors de la zone de séparation (40) afin d'obtenir une capacité de séparation normale. Le système (30) recycle en outre le premier constituant cellulaire (36) vers la zone (40). En recyclant en continu le premier constituant cellulaire (36) vers la zone de séparation (40), le système (30) permet d'obtenir et de maintenir un volume désiré du premier constituant (36), peu importe le volume de la suspension (32) riche en matière cellulaire traité. Grâce à ce recyclage continu du premier constituant (36) dans la zone de séparation (40), le système (30) permet aussi de créer dans cette zone (40) des conditions de fonctionnement qui maximisent les capacités de séparation mais qui, sans les avantages du recyclage, pourraient autrement traumatiser le premier constituant cellulaire (36) ou en provoquer la détérioration.
Patent EP-0573455-A1 (EP)
Inventor: DAVIES STEPHEN GRAHAM
IPC: A61K31/357
Filed: 1992-02-17
Abstract: On effectue la synthèse de (+)-pilocarpine par l'intermédiaire de propane-1,3-diols monoprotégés homochiraux préparés dans > 98 % d'excès énantiomère par acylation catalysée enzymatiquement du diol correspondant, ainsi que des lactones dérivés, ou par l'intermédiaire d'alcools acétyléniques qui, par imidazolisation et carbonylation catalysée, sont convertis en lactones, ce qui produit encore des pilocarpines et leurs analogues.
Patent EP-0521143-A1 (EP)
Inventor: DIPIPPO ASCANIO G
IPC: A61L15/48
Filed: 1992-01-17
Abstract: Pansement pour brûlure se présentant sous forme d'un tissu synthétique non tissé et non irritant renfermant un gel thérapeutique, non toxique, soluble dans l'eau et biodégradable. Les ingrédients de base du gel sont l'eau et l'huile d'arbre à thé et/ou un mélange d'arbre à thé. On utilise un matériau gummifère ou un agent épaississant pour conserver l'eau et l'huile d'arbre à thé et/ou le mélange d'arbre à thé à l'état de gel ou de fluide épais. D'autres ingrédients sont également prévus pour augmenter la durée de conversation du gel et pour lui conférer des propriétés bactériostatiques et de pénétration dans la peau.
Patent EP-0539559-A1 (EP)
Inventor: FRANKE HANS-GEORGE
IPC: H01L21/3065
Filed: 1992-04-01
Abstract: L'invention décrit un masque permettant la fabrication de dispositifs en GaAs, tels que des guides d'ondes, des canaux, des facettes, des mesas et des miroirs, au moyen d'un traitement d'attaque à sec dans des environnements contenant du chlore. Le masque est constitué par une forme amorphe de carbone pouvant contenir de l'hydrogène incorporé. On peut appliquer, retirer et réaliser des motifs sur le masque au moyen de techniques de traitement à sec.
Patent EP-0600917-A1 (EP)
Inventor: ALBREKTSSON BJOERN
IPC: A61B17/80
Filed: 1992-07-07
Abstract: PCT No. PCT/SE92/00511 Sec. 371 Date May 2, 1994 Sec. 102(e) Date May 2, 1994 PCT Filed Jul. 4, 1992 PCT Pub. No. WO93/01769 PCT Pub. Date Feb. 4, 1993A hip joint prosthesis to be permanently anchored in a patient's hip is disclosed. The prosthesis comprises an attachment part for a ball unit designed to be anchored in the neck of a human femur. The attachment part comprises a primary fixture which may be an elongate anchoring element which is intended to be inserted into a channel extending through the femoral collum. The prosthesis also includes a secondary fixture for carrying a ball intended to be attached to the collum after removal of the head of the collum. The primary fixture and the secondary fixture are connected to each other. The prosthesis is preferably designed so that the length of the primary fixture terminates close to the head of the collum. The secondary fixture preferably comprises a plug-like part which is intended to be inserted in a cylindrical countersunk recess that is cut into the cancellous bone of the collum and which extends to the cortical bone in at least three locations.
Patent EP-0594764-A1 (EP)
Title: Hematopoietic growth factor derived from t lymphocytes and methods of use therefor
Inventor: CHOUDHURY CHANDRA
IPC: C12Q1/68
Filed: 1992-07-07
Abstract: A T cell-derived colony stimulating factor (TC-CSF) may be isolated from media conditioned with T lymphocyte cells. TC-CSF stimulates formation of colonies composed of granulocytes, macrophages, megakaryocytes, fibrocytic stromal cells, lymphocytes, and mixed colonies of granulocytes and macrophages. Anion exchange chromatography may be employed in conjunction with gel filtration and rpHPLC to isolate TC-CSF. Human TC-CSF and murine TC-CSF cDNA, mRNA, genomic DNA nucleotide and amino acid sequences, expression products, pharmaceutical formulations and antibody materials are specifically provided.
Patent EP-0598029-A1 (EP)
Title: Retroviral vectors containing internal ribosome entry sites
Inventor: ANDERSON W FRENCH
IPC: C07K14/085
Filed: 1992-08-06
Abstract: This invention relates to the production of a retroviral vector which is capable of expressing multiple protein translation events from a single polycistronic mRNA, by using internal ribosome entry sites in place of an internal promoter.
Patent EP-0600982-A1 (EP)
Inventor: DOLAN SHAWN E
IPC: C23C22/34
Filed: 1992-08-12
Abstract: Revêtement métallique obtenu par conversion chimique, sans chrome, au moins équivalent, pour ce qui est de ses propriétés de protection contre la corrosion, aux revêtements conventionnels contenant du chrome (VI), qui peut être formé sur des métaux, en particulier sur de l'acier galvanisé, par application d'un liquide aqueux acide séchant en place comprenant (a) un constituant d'anions, chacun desdits anions étant constitué (i) d'au moins quatre atomes de fluor et (ii) d'au moins un atome d'un élément sélectionné dans le groupe formé du titane, de zirconium, du hafnium, du silicium et du bore et, éventuellement, (iii) d'un ou plusieurs atomes d'oxygène, (b) un constituant de cations d'éléments sélectionnés dans le groupe formé du cobalt, du magnésium, du manganèse, du zinc, du nickel, de l'étain, du zirconium, du fer, de l'aluminium et du cuivre, le rapport du nombre total de cations de ce constituant au nombre total d'anions du constituant (a) étant d'au moins 2:5, et (c) une quantité suffisante d'acide libre pour conférer à la composition, après dilution avec de 1 à 19 fois son propre poids d'eau, un pH de l'ordre de 0,5 à 5,0 et, éventuellement (d) une composition qui formera un film résineux organique après séchage sur place.
Patent EP-0603311-A1 (EP)
Inventor: VENAILLE CHRISTOPHE
IPC: G01N21/88
Filed: 1992-09-14
Abstract: Le procédé consiste: à illuminer par un rayonnement laser des plans de coupe (YZ) successifs du morceau de verre à inspecter, par déplacement relatif d'un rideau lumineux formé à partir d'une source d'éclairage de type laser et du morceau de verre à inspecter; à détecter, par une caméra, le rayonnement réfléchi émergeant du morceau de verre dans une direction d'observation oblique par rapport au plan (YZ) du rideau lumineux, de sorte que l'image formée par la caméra comporte deux lignes correspondant aux faces supérieure et inférieure du morceau de verre et éventuellement des points lumineux situés entre ces deux lignes correspondant à des inclusions dans l'épaisseur du verre. L'invention s'applique, notamment, au contrôle de qualité du verre en sortie de fabrication.
Patent EP-0575720-A1 (EP)
Inventor: FRITSCHLE STEFAN
IPC: F16D55/224
Filed: 1993-04-16
Abstract: Hydraulically actuated rim brake (1) for bicycles with a carrier (2) which is attached to a frame component of the bicycle and on which a lever arm (4a, 4b) is pivotably mounted on an axle bolt (3) in each case on the left-hand side and right-hand side of a wheel (6) of the bicycle, the lever arms being connected on the one hand to at least one hydraulic cylinder (5) and on the other hand each bearing a brake block (7) which engages on a rim brake (6a) of the wheel. In each case gear elements (8) are rigidly arranged on the lever arms, the said elements (8) being in mutual positive engagement and only permitting a common pivoting movement on the lever arms in opposite directions. <IMAGE>
Patent EP-0567079-A1 (EP)
Inventor: MORITA YOSHITSUGU TORAY DOW CO
IPC: C08L83/14
Filed: 1993-04-20
Abstract: The instant invention pertains to a curable resin composition comprised of A) 100 parts by weight curable resin, and B) 0.1-500 parts by weight of an organopolysiloxane having organic groups that contain epoxy groups, which is expressed by the formula:
       
 wherein R¹ is a univalent hydrocarbon group excluding alkenyl groups, R² is a hydrogen atom or a univalent hydrocarbon group excluding alkenyl groups, R³ is an alkoxysilylalkyl group or an organic group that contains epoxy groups,  a  is 0 or a positive integer,  b  is a positive integer and  c  is a positive integer, where a/c has the value of 0 to 4, b/c has the value of 0.05 to 4 and        (a+b)/c           has the value of 0.2 to 4. The curable resin composition of the instant invention has superior flowability that produces a hardened resin with superior flexibility and adhesion.
Patent EP-0571778-A1 (EP)
Inventor: HARASHIMA ASAO
IPC: B01F27/73
Filed: 1993-04-29
Abstract: A method for producing powder mixtures capable of inducing an even more intimate, microhomogeneous intermixing in a heterogeneous powder composed of at least two types of powders. The method is effective even for the mixing of an aggregable powder and a nonaggregable powder. According to the method, a heterogeneous powder composed of at least two types of powders that have been preliminarily mixed by stirring is introduced into an inlet (5) while a rotating axle (1) is turning and is axially transported within a cylinder by a screw (7). As the heterogeneous powder passes between rotating disks (3) and fixed disks (4), it is subjected to a highly efficient mixing by compression and shear forces due to a sliding-shear action exerted between depressions and elevations (31,32;41,42) installed on the opposing surfaces of the rotating disks and fixed disks. The mixture passes in sequence through multiple stages of the rotating and fixed disks. A powder mixture, which has been microhomogeneously interdispersed, is discharged from the outlet.
Patent EP-0569826-A1 (EP)
Inventor: LUDWIG FRANK A
IPC: C23C22/77
Filed: 1993-05-04
Abstract: A method and system for monitoring the quality of a phosphate coating on a metal surface having a large surface area. The method comprises applying a current or potential between the metal surface and one or more counter electrodes while they are in the phosphating solution and superimposing a constant ac signal thereon. An ac impedance spectra is obtained by measuring the ac potential between the metal substrate and one or more reference electrodes located between the counter electrode and the substrate. The ac impedance spectra provide an indication of defects in the phosphate coating even when the defects are located within a relatively small region of the total surface area of the metal surface.
Patent EP-0580018-A1 (EP)
Inventor: KORTHAUS ERNST DIPL-ING
IPC: F04B11/00
Filed: 1993-07-07
Abstract: In a concrete-conveying arrangement on a concrete-conveying pump (1), a connection conveying line (2) to the multi-part concrete-conveying mast (3), a concrete-conveying mast and a concrete-conveying line (4) integrated on the concrete-conveying mast, a solution is to be found, with which the values of the operating loads and inherent loads according to DIN 24117 no longer have to be multiplied by 1.3 and 1.2 respectively for reasons of safety. This is achieved by installing a tubular accumulator (6) with an internal hose (9) made of polyurethane with a Shore D hardness which is equal to or greater than 27. <IMAGE>
Patent EP-0583771-A1 (EP)
Inventor: KRIGMONT HENRY V
IPC: F23J15/00
Filed: 1993-08-17
Abstract: The NOx content in a flow of flue gas is reduced by passing the flue gas through a first treatment zone and a second treatment zone. A nitrogeneous treatment agent is introduced into the first treatment zone for the selective non-catalytic reduction of part of the NOx, and the flue gas is thereafter passed through the second treatment zone which includes a catalyst for further selective catalytic reduction of the NOx. Optionally, a second nitrogeneous treatment agent is added to the flue gas in the second treatment zone. The quantity of NOx in the flue gas is detected intermediate the first and second treatment zones and, optionally, after the flue gas has left the second treatment zone. The quantity of ammonia in the flue gas exiting from the second treatment zone is also detected. The amounts of the treatment agents added to the flue gas are controlled responsive to the variations and absolute levels determined by these measurements.
Patent EP-0596371-A1 (EP)
Inventor: DE PIERI BRUNO
IPC: E04B2/02
Filed: 1993-10-25
Abstract: The building block (1) has a hollow body (2) with lateral surfaces (3) which bear a decorative finish, a flat upper surface (4) having studs (6) protruding therefrom, and a bottom opening defining seats for accommodating the upwardly protruding studs (6) of an underlying block. A frog (9) is formed in the flat upper surface (4) for permitting the introduction of an adhesive medium between adjacent blocks. The block (1) can be provided with a framework (23) having an upper frame (27) and legs (26) for interposition between adjacent blocks.